A five-day hypocaloric and ketogenic program delivered remotely
Metabolic Effects of a Five-day Remotely Delivered Hypocaloric and Ketogenic Program in Healthy Subjects
This study is testing if a five-day low-calorie and ketogenic meal plan delivered online can improve health and metabolism for people looking to make dietary changes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 64 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Buchinger Wilhelmi Development & Holding GmbH Academic / other |
| Locations | 1 site (Überlingen, Baden-Württemberg) |
| Trial ID | NCT05821660 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the metabolic effects of a five-day hypocaloric and ketogenic program designed for remote delivery. The program focuses on dietary interventions that can be easily integrated into daily life, utilizing ready-to-eat soups made from organic ingredients to provide a total daily intake of around 600 kcal. The study builds on previous research indicating that fasting can improve various health markers, including inflammation and metabolic health, particularly in the context of lifestyle changes prompted by the COVID-19 pandemic.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals seeking to improve their nutrition and lifestyle through a structured dietary program.
Not a fit: Patients with severe medical conditions such as advanced kidney or liver insufficiency, diabetes, or those currently on certain medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could offer a practical dietary intervention for improving metabolic health and managing weight.
How similar studies have performed: Previous studies on fasting and ketogenic diets have shown promising results, indicating that this approach may be effective, although this specific program is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Exclusion Criteria: * Not able to sign the informed consent * diagnosticated with cachexia, anorexia, nervosa, advanced kidney, liver or cerebrovascular insufficiency. * Intake of antibiotics up to 2 months prior the study * Medicated high blood pressure * Diagnosed hyperuricemia * Diagnosed diabetes mellitus type I and II * Diagnosed kidney stone * Active malignant diseases * Known substance addiction * Pregnancy or breastfeeding * Participation in another study
Where this trial is running
Überlingen, Baden-Württemberg
- Buchinger Wilhelmi Clinic — Überlingen, Baden-Württemberg, Germany (Recruiting)
Study contacts
- Principal investigator: Françoise Wilhelmi de Toledo, Dr. — Buchinger Wilhelmi
- Study coordinator: Buchinger Wilhelmi Clinic
- Email: forschung@buchinger-wilhelmi.com
- Phone: +49-7551-8070
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.